Evidence map›Paper›PMID 32802957›Full record

ArticleNeurology. Genetics2020

Christiane M Neuhofer, Claudia B Catarino, Heinrich Schmidt, Klaus Seelos, Bader Alhaddad, Tobias B Haack, Thomas Klopstock

Open access · goldAbstract read
In one paragraph

Article in Neurology. Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Christiane M NeuhoferFriedrich-Baur-Institute (C.M.N., C.B.C., T.K.), Department of Neurology, University Hospital, LMU Munich, Germany; Institute of Human Genetics (C.M.N.), University Medical Center Göttingen, Germany; Department of Pediatrics (H.S.), Medical Genetics, Dr. von Haunersches Kinderspital, University Hospital, LMU Munich, Germany; Department of Neuroradiology (K.S.), University Hospital, LMU Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Technical University Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Helmholtz Zentrum München, Neuherberg, Germany; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy) (T.K.), Munich, Germany.ORCID 0000-0002-5037-4444
Claudia B CatarinoFriedrich-Baur-Institute (C.M.N., C.B.C., T.K.), Department of Neurology, University Hospital, LMU Munich, Germany; Institute of Human Genetics (C.M.N.), University Medical Center Göttingen, Germany; Department of Pediatrics (H.S.), Medical Genetics, Dr. von Haunersches Kinderspital, University Hospital, LMU Munich, Germany; Department of Neuroradiology (K.S.), University Hospital, LMU Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Technical University Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Helmholtz Zentrum München, Neuherberg, Germany; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy) (T.K.), Munich, Germany.ORCID 0000-0002-6528-7570
Heinrich SchmidtFriedrich-Baur-Institute (C.M.N., C.B.C., T.K.), Department of Neurology, University Hospital, LMU Munich, Germany; Institute of Human Genetics (C.M.N.), University Medical Center Göttingen, Germany; Department of Pediatrics (H.S.), Medical Genetics, Dr. von Haunersches Kinderspital, University Hospital, LMU Munich, Germany; Department of Neuroradiology (K.S.), University Hospital, LMU Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Technical University Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Helmholtz Zentrum München, Neuherberg, Germany; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy) (T.K.), Munich, Germany.ORCID 0000-0003-1329-0118
Klaus SeelosFriedrich-Baur-Institute (C.M.N., C.B.C., T.K.), Department of Neurology, University Hospital, LMU Munich, Germany; Institute of Human Genetics (C.M.N.), University Medical Center Göttingen, Germany; Department of Pediatrics (H.S.), Medical Genetics, Dr. von Haunersches Kinderspital, University Hospital, LMU Munich, Germany; Department of Neuroradiology (K.S.), University Hospital, LMU Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Technical University Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Helmholtz Zentrum München, Neuherberg, Germany; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy) (T.K.), Munich, Germany.
Bader AlhaddadFriedrich-Baur-Institute (C.M.N., C.B.C., T.K.), Department of Neurology, University Hospital, LMU Munich, Germany; Institute of Human Genetics (C.M.N.), University Medical Center Göttingen, Germany; Department of Pediatrics (H.S.), Medical Genetics, Dr. von Haunersches Kinderspital, University Hospital, LMU Munich, Germany; Department of Neuroradiology (K.S.), University Hospital, LMU Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Technical University Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Helmholtz Zentrum München, Neuherberg, Germany; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy) (T.K.), Munich, Germany.ORCID 0000-0003-4542-5267
Tobias B HaackFriedrich-Baur-Institute (C.M.N., C.B.C., T.K.), Department of Neurology, University Hospital, LMU Munich, Germany; Institute of Human Genetics (C.M.N.), University Medical Center Göttingen, Germany; Department of Pediatrics (H.S.), Medical Genetics, Dr. von Haunersches Kinderspital, University Hospital, LMU Munich, Germany; Department of Neuroradiology (K.S.), University Hospital, LMU Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Technical University Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Helmholtz Zentrum München, Neuherberg, Germany; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy) (T.K.), Munich, Germany.
Thomas KlopstockFriedrich-Baur-Institute (C.M.N., C.B.C., T.K.), Department of Neurology, University Hospital, LMU Munich, Germany; Institute of Human Genetics (C.M.N.), University Medical Center Göttingen, Germany; Department of Pediatrics (H.S.), Medical Genetics, Dr. von Haunersches Kinderspital, University Hospital, LMU Munich, Germany; Department of Neuroradiology (K.S.), University Hospital, LMU Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Technical University Munich, Germany; Institute of Human Genetics (B.A., T.B.H.), Helmholtz Zentrum München, Neuherberg, Germany; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy) (T.K.), Munich, Germany.ORCID 0000-0003-2805-4652
German Center for Neurodegenerative Diseases · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveClinical, neuroimaging, and genetic characterization of 3 patients with

methodsThree affected brothers from a consanguineous family from Afghanistan, their 2 healthy siblings, and both parents were all assessed in the clinic. General and neurologic examination, expert dysmorphology examination, and 3T brain MRI were performed. Whole-exome sequencing was performed for the 3 affected brothers, followed by Sanger sequencing in all available family members.

resultsThe index patient and his 2 affected brothers presented a complex neurologic syndrome with similar features but marked intrafamilial phenotypical variability, including varying degrees of cognitive impairment, speech impairment, dystonia, abnormal eye movements, and dysmorphic features. All 3 affected brothers are homozygous for a novel, pathogenic frameshift mutation in

conclusionThis consanguineous family with a novel mutation expands the spectrum of

Identifiers

PMID32802957
PMCPMC7413627
OpenAlexW3047408779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.